Comprehensive Stock Comparison
Compare Nutanix, Inc. (NTNX) vs Core Scientific, Inc. (CORZ) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | NTNX | 18.1% revenue growth vs CORZ's 1.6% |
| Value | NTNX | Lower P/E (21.1x vs 314.8x) |
| Quality / Margins | NTNX | 9.9% net margin vs CORZ's -229.9% |
| Stability / Safety | NTNX | Beta 1.25 vs CORZ's 2.06 |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | CORZ | +52.1% vs NTNX's -50.2% |
| Efficiency (ROA) | NTNX | 8.2% ROA vs CORZ's -33.5% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Nutanix provides a hyperconverged infrastructure platform that combines computing, storage, and virtualization into a single software solution. It generates revenue primarily through subscription software licenses — about 90% of total revenue — with the remainder from hardware sales and support services. The company's key advantage is its software-defined architecture that simplifies data center management and enables seamless hybrid cloud operations.
Core Scientific operates large-scale Bitcoin mining facilities and provides colocation hosting services for other miners. It generates revenue primarily from mining Bitcoin for its own account—earning block rewards and transaction fees—and from hosting fees paid by third-party miners who use its infrastructure. The company's competitive advantage lies in its scale, operational expertise, and strategic partnerships with major hardware manufacturers, which provide access to efficient mining equipment.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
NTNX leads in 3 of 6 categories (Financial Metrics, Valuation Metrics). CORZ leads in 1 (Total Returns). 1 tied.
Financial Metrics (TTM)
NTNX is the larger business by revenue, generating $2.7B annually — 8.0x CORZ's $334M. NTNX is the more profitable business, keeping 9.9% of every revenue dollar as net income compared to CORZ's -2.3%. On growth, NTNX holds the edge at +10.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | NTNXNutanix, Inc. | CORZCore Scientific, … |
|---|---|---|
| RevenueTrailing 12 months | $2.7B | $334M |
| EBITDAEarnings before interest/tax | $288M | -$82M |
| Net IncomeAfter-tax profit | $267M | -$768M |
| Free Cash FlowCash after capex | $777M | -$354M |
| Gross MarginGross profit ÷ Revenue | +87.1% | +6.5% |
| Operating MarginEBIT ÷ Revenue | +8.0% | -52.1% |
| Net MarginNet income ÷ Revenue | +9.9% | -2.3% |
| FCF MarginFCF ÷ Revenue | +28.9% | -106.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.4% | -14.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +89.5% | +70.5% |
Valuation Metrics
On an enterprise value basis, NTNX's 45.2x EV/EBITDA is more attractive than CORZ's 55.5x.
| Metric | NTNXNutanix, Inc. | CORZCore Scientific, … |
|---|---|---|
| Market CapShares × price | $10.4B | $5.2B |
| Enterprise ValueMkt cap + debt − cash | $11.1B | $5.6B |
| Trailing P/EPrice ÷ TTM EPS | 58.89x | -3.30x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.13x | 314.84x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 45.16x | 55.45x |
| Price / SalesMarket cap ÷ Revenue | 4.08x | 10.25x |
| Price / BookPrice ÷ Book value/share | — | — |
| Price / FCFMarket cap ÷ FCF | 13.81x | — |
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), NTNX scores 6/9 vs CORZ's 5/9, reflecting solid financial health.
| Metric | NTNXNutanix, Inc. | CORZCore Scientific, … |
|---|---|---|
| ROE (TTM)Return on equity | — | — |
| ROA (TTM)Return on assets | +8.2% | -33.5% |
| ROICReturn on invested capital | +6.9% | — |
| ROCEReturn on capital employed | +12.5% | -2.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | — | — |
| Net DebtTotal debt minus cash | $713M | $364M |
| Cash & Equiv.Liquid assets | $770M | $836M |
| Total DebtShort + long-term debt | $1.5B | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | 12.48x | -418.37x |
Total Returns (with DRIP)
A $10,000 investment in CORZ five years ago would be worth $49,331 today (with dividends reinvested), compared to $12,465 for NTNX. Over the past 12 months, CORZ leads with a +52.1% total return vs NTNX's -50.2%. The 3-year compound annual growth rate (CAGR) favors CORZ at 70.2% vs NTNX's 10.7% — a key indicator of consistent wealth creation.
| Metric | NTNXNutanix, Inc. | CORZCore Scientific, … |
|---|---|---|
| YTD ReturnYear-to-date | -24.3% | +6.1% |
| 1-Year ReturnPast 12 months | -50.2% | +52.1% |
| 3-Year ReturnCumulative with dividends | +35.5% | +393.3% |
| 5-Year ReturnCumulative with dividends | +24.6% | +393.3% |
| 10-Year ReturnCumulative with dividends | +3.5% | +393.3% |
| CAGR (3Y)Annualised 3-year return | +10.7% | +70.2% |
Risk & Volatility
NTNX is the less volatile stock with a 1.25 beta — it tends to amplify market swings less than CORZ's 2.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CORZ currently trades 71.8% from its 52-week high vs NTNX's 45.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | NTNXNutanix, Inc. | CORZCore Scientific, … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.25x | 2.06x |
| 52-Week HighHighest price in past year | $83.36 | $23.63 |
| 52-Week LowLowest price in past year | $35.39 | $6.20 |
| % of 52W HighCurrent price vs 52-week peak | +45.9% | +71.8% |
| RSI (14)Momentum oscillator 0–100 | 43.7 | 52.4 |
| Avg Volume (50D)Average daily shares traded | 3.5M | 8.6M |
Analyst Outlook
Wall Street rates NTNX as "Buy" and CORZ as "Buy". Consensus price targets imply 61.3% upside for CORZ (target: $27) vs 58.2% for NTNX (target: $61).
| Metric | NTNXNutanix, Inc. | CORZCore Scientific, … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $60.55 | $27.38 |
| # AnalystsCovering analysts | 31 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Feb 24 | Feb 26 | Change |
|---|---|---|---|
| Nutanix, Inc. (NTNX) | 100 | 70.25 | -29.7% |
| Core Scientific, In… (CORZ) | 77.62 | 519.48 | +569.3% |
Core Scientific, In… (CORZ) returned +393% over 5 years vs Nutanix, Inc. (NTNX)'s +25%. A $10,000 investment in CORZ 5 years ago would be worth $49,331 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Nutanix, Inc. (NTNX) | $503M | $2.5B | +404.1% |
| Core Scientific, In… (CORZ) | $60M | $511M | +757.9% |
Nutanix, Inc.'s revenue grew from $503M (2016) to $2.5B (2025) — a 19.7% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Nutanix, Inc. (NTNX) | -21.5% | 7.4% | +134.5% |
| Core Scientific, In… (CORZ) | -20.0% | -2.6% | +87.1% |
Nutanix, Inc.'s net margin went from -22% (2016) to 7% (2025).
Chart 4EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Nutanix, Inc. (NTNX) | -0.79 | 0.65 | +182.3% |
| Core Scientific, In… (CORZ) | -0.28 | -5.14 | -1735.7% |
Nutanix, Inc.'s EPS grew from $-0.79 (2016) to $0.65 (2025).
Chart 5Free Cash Flow — 5 Years
Nutanix, Inc. generated $750M FCF in 2025 (+573% vs 2021). Core Scientific, Inc. generated $-52M FCF in 2024 (+55% vs 2021).
NTNX vs CORZ: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is NTNX or CORZ a better buy right now?
Nutanix, Inc. (NTNX) offers the better valuation at 58.9x trailing P/E (21.1x forward), making it the more compelling value choice. Analysts rate Nutanix, Inc. (NTNX) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NTNX or CORZ?
On forward P/E, Nutanix, Inc. is actually cheaper at 21.1x.
03Which is the better long-term investment — NTNX or CORZ?
Over the past 5 years, Core Scientific, Inc. (CORZ) delivered a total return of +393.3%, compared to +24.6% for Nutanix, Inc. (NTNX). A $10,000 investment in CORZ five years ago would be worth approximately $49K today (assuming dividends reinvested). Over 10 years, the gap is even starker: CORZ returned +393.3% versus NTNX's +3.5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NTNX or CORZ?
By beta (market sensitivity over 5 years), Nutanix, Inc. (NTNX) is the lower-risk stock at 1.25β versus Core Scientific, Inc.'s 2.06β — meaning CORZ is approximately 65% more volatile than NTNX relative to the S&P 500.
05Which has better profit margins — NTNX or CORZ?
Nutanix, Inc. (NTNX) is the more profitable company, earning 7.4% net margin versus -257.5% for Core Scientific, Inc. — meaning it keeps 7.4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NTNX leads at 6.8% versus -3.8% for CORZ. At the gross margin level — before operating expenses — NTNX leads at 86.8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is NTNX or CORZ more undervalued right now?
On forward earnings alone, Nutanix, Inc. (NTNX) trades at 21.1x forward P/E versus 314.8x for Core Scientific, Inc. — 293.7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CORZ: 61.3% to $27.38.
07Which pays a better dividend — NTNX or CORZ?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is NTNX or CORZ better for a retirement portfolio?
For long-horizon retirement investors, Nutanix, Inc. (NTNX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.25)). Core Scientific, Inc. (CORZ) carries a higher beta of 2.06 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NTNX: +3.5%, CORZ: +393.3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between NTNX and CORZ?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.